Logo image of APEN

APOLLO ENDOSURGERY INC (APEN) Stock Analyst Earnings Estimates

NASDAQ:APEN - Nasdaq - US03767D1081 - Common Stock - Currency: USD

10  +0.08 (+0.81%)

After market: 9.99 -0.01 (-0.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
APEN revenue by date.APEN revenue by date.
42.05M
-17.08%
62.989M
49.80%
76.856M
22.01%
91.023M
18.43%
111.2M
22.17%
184.47M
65.89%
EBITDA
YoY % growth
APEN ebitda by date.APEN ebitda by date.
-12.06M
51.88%
-15.967M
-32.40%
-24.856M
-55.67%
-17.33M
30.28%
-13.182M
23.94%
N/A
EBIT
YoY % growth
APEN ebit by date.APEN ebit by date.
-15.79M
45.78%
-19.199M
-21.59%
-27.822M
-44.91%
-29.618M
-6.46%
-26.049M
12.05%
-27.671M
-6.22%
Operating Margin
APEN operating margin by date.APEN operating margin by date.
-37.55%-30.48%-36.20%-32.54%-23.43%-15.00%
EPS
YoY % growth
APEN eps by date.APEN eps by date.
-1.04
31.58%
-0.89
14.42%
-0.98
-9.99%
-0.85
13.10%
-0.73
13.67%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.22
-5.24%
-0.22
16.31%
-0.20
28.36%
-0.19
15.35%
-0.19
12.31%
-0.18
15.62%
-0.14
28.81%
-0.13
31.58%
Revenue
Q2Q % growth
20.25M
21.53%
22.921M
18.72%
23.452M
19.82%
24.527M
15.07%
23.964M
18.34%
26.406M
15.20%
27.393M
16.80%
29.342M
19.63%
EBITDA
Q2Q % growth
-5.14M
21.00%
-4.923M
3.47%
-4.389M
-8.54%
-4.318M
8.91%
-5.145M
-0.10%
-4.378M
11.07%
-2.857M
34.91%
-2.175M
49.63%
EBIT
Q2Q % growth
-7.806M
-7.72%
-7.612M
-15.72%
-7.138M
-13.46%
-6.781M
12.00%
-7.692M
1.47%
-7.024M
7.73%
-5.506M
22.86%
-4.871M
28.18%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
-0.23
15.21%
-0.21-0.02-7.91%
Q3 2022
Q2Q % growth
-0.28
-21.74%
-0.24-0.04-18.32%
Q2 2022
Q2Q % growth
-0.26
-18.18%
-0.23-0.03-13.29%
Q1 2022
Q2Q % growth
-0.21
-23.53%
-0.20-0.01-4.68%
Q4 2021
Q2Q % growth
-0.27
-92.86%
-0.20-0.07-38.11%
Q3 2021
Q2Q % growth
-0.23
-109.09%
-0.290.0619.47%
Q2 2021
Q2Q % growth
-0.22
26.67%
-0.20-0.02-9.67%
Q1 2021
Q2Q % growth
-0.17
65.31%
-0.220.0524.24%
Q4 2020
Q2Q % growth
-0.14
58.82%
-0.260.1246.17%
Q3 2020
Q2Q % growth
-0.11
72.50%
-0.210.1048.65%
Q2 2020
Q2Q % growth
-0.30
25.00%
-0.340.0410.87%
Q1 2020
Q2Q % growth
-0.49
-28.95%
-0.500.011.96%
Q4 2019
Q2Q % growth
-0.34 -0.390.0512.28%
Q3 2019
Q2Q % growth
-0.40 -0.430.036.63%
Q2 2019
Q2Q % growth
-0.40 -0.39-0.01-3.20%
Q1 2019
Q2Q % growth
-0.38 -0.37-0.01-2.07%
APEN Yearly EPS VS EstimatesAPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
21.314M
31.80%
20.278M1.036M5.11%
Q3 2022
Q2Q % growth
19.573M
19.71%
18.51M1.063M5.74%
Q2 2022
Q2Q % growth
19.307M
16.24%
18.644M663K3.56%
Q1 2022
Q2Q % growth
16.662M
20.22%
16.13M532K3.30%
Q4 2021
Q2Q % growth
16.171M
25.75%
16.57M-399K-2.41%
Q3 2021
Q2Q % growth
16.351M
27.44%
15.707M644K4.10%
Q2 2021
Q2Q % growth
16.61M
194.50%
13.948M2.662M19.09%
Q1 2021
Q2Q % growth
13.86M
29.29%
11.943M1.917M16.05%
Q4 2020
Q2Q % growth
12.86M
7.26%
11.23M1.63M14.51%
Q3 2020
Q2Q % growth
12.83M
13.94%
10.177M2.653M26.07%
Q2 2020
Q2Q % growth
5.64M
-60.42%
5.292M348K6.58%
Q1 2020
Q2Q % growth
10.72M
-18.85%
8.908M1.812M20.34%
Q4 2019
Q2Q % growth
11.99M 12.698M-708K-5.58%
Q3 2019
Q2Q % growth
11.26M 12.991M-1.731M-13.32%
Q2 2019
Q2Q % growth
14.25M 13.842M408K2.95%
Q1 2019
Q2Q % growth
13.21M 13.472M-262K-1.94%
APEN Yearly Revenue VS EstimatesAPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%